首页> 外文期刊>Molecular cancer research: MCR >CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling.
【24h】

CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling.

机译:CNK1通过依赖NF-κB的信号传导促进癌细胞的侵袭。

获取原文
获取原文并翻译 | 示例
           

摘要

Hallmarks of cancer cells are uncontrolled proliferation, evasion of apoptosis, angiogenesis, cell invasion, and metastasis, which are driven by oncogenic activation of signaling pathways. Herein, we identify the scaffold protein CNK1 as a mediator of oncogenic signaling that promotes invasion in human breast cancer and cervical cancer cells. Downregulation of CNK1 diminishes the invasiveness of cancer cells and correlates with reduced expression of matrix metalloproteinase 9 (MMP-9) and membrane-type 1 MMP (MT1-MMP). Ectopic expression of CNK1 elevates MT1-MMP promoter activity in a NF-kappaB-dependent manner. Moreover, CNK1 cooperates with the NF-kappaB pathway, but not with the extracellular signal-regulated protein kinase pathway, to promote cell invasion. Mechanistically, CNK1 regulates the alternative branch of the NF-kappaB pathway because knockdown of CNK1 interferes with processing of NF-kappaB2 p100 to p52 and its localization to the nucleus. In agreement with this, the invasion of CNK1-depleted cells is less sensitive to RelB downregulation compared with the invasion of control cells. Moreover, CNK1-dependent MT1-MMP promoter activation is blocked by RelB siRNA. Thus, CNK1 is an essential mediator of an oncogenic pathway involved in invasion of breast and cervical cancer cells and is therefore a putative target for cancer therapy.
机译:癌细胞的标志是不受控制的增殖,逃避凋亡,血管生成,细胞侵袭和转移,这是由信号通路的致癌激活驱动的。在本文中,我们确定了支架蛋白CNK1是致癌信号传导的介质,可促进人乳腺癌和宫颈癌细胞的侵袭。 CNK1的下调减少了癌细胞的侵袭性,并与基质金属蛋白酶9(MMP-9)和1型膜MMP(MT1-MMP)的表达降低有关。 CNK1的异位表达以NF-κB依赖性的方式提高了MT1-MMP启动子的活性。此外,CNK1与NF-κB途径协同作用,但与细胞外信号调节的蛋白激酶途径不起作用,以促进细胞侵袭。从机理上讲,CNK1调节NF-kappaB途径的另一分支,因为CNK1的敲低会干扰NF-kappaB2 p100到p52的加工及其在细胞核中的定位。与此一致的是,与对照细胞的侵袭相比,耗尽CNK1的细胞对RelB下调的敏感性较低。此外,依赖CNK1的MT1-MMP启动子激活被RelB siRNA阻断。因此,CNK1是参与乳腺癌和宫颈癌细胞侵袭的致癌途径的重要介质,因此是癌症治疗的假定靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号